Drug development

Vaccine
#Clinical trials #Drug development #Drug discovery #Vaccines

Developing a new targeted vaccine for Pneumococcal disease in Malawi 

Earlier this year, the Infection Innovation Consortium: iiCON and partners launched the first human challenge trial for a new vaccine for pneumococcal disease – marking a key milestone in a collaborative global project that is offering new hope in the fight against the disease. Professor Stephen Gordon, Director of Experimental… Read More

#Exclusive Content

Business financing
#Artificial intelligence (AI) #Drug development #Drug discovery #Financing

Tres Alchemix closes $4.4 million financing round

AI-driven biotechnology company Tres Alchemix has closed its $4.4 million Series A financing round, the company has announced.  New funding will be used to accelerate the development of Tres Alchemix’s predictive AI platform and support the opening of a new laboratory at The Oxford Science Park, a hub of world-leading… Read More

#Business & Investment #News #Start-up Zone

Vaccine
#Drug development #Drug discovery #Immunology / Virology & Vaccines #mRNA-based vaccines

The expanding market of vaccines  

By Stephen Adams, Associate Director, Optimum Strategic Communications  To say that vaccines and vaccine makers have been on a popularity rollercoaster in recent years is an understatement. Five years ago, with the world’s biotechs and pharma firms engaged in a high-stakes race to develop the first Covid vaccines, the mood… Read More

#Exclusive Content

#Drug design #Drug development #Webinar

Don’t miss this webinar on breakthroughs in drug design

Don’t miss this webinar on how X-ray crystallography can accelerate the drug design process, hosted by DDW and supported by Curia. The first challenge in drug discovery is selecting a biological target and validating it as a ‘druggable’ binding site. The key to this is identifying several potent compounds that… Read More

#News

Human heart
#Cardiovascular disease #Clinical trials #Drug development #Drug discovery

Can human mini-Hearts advance cardiovascular drug development?

By Ronald A Li, PhD, CEO and Co-Founder, Medera, and Kevin D Costa, PhD, Co-Founder, Novoheart. Recent NIH policy prioritising the use of New Approach Methodologies (NAMs) as alternatives to laboratory animals in all new funding opportunities marks a seismic shift in how biomedical research will be conducted. For a… Read More

#Exclusive Content

Tumour microenvironment
#Cancer #Drug development #Tumour microenvironment (TME) #Whitepaper

Whitepaper: How protein biomarkers can impact cancer outcomes

Download this whitepaper by Standard BioTools to learn about the tumour microenvironment (TME) and the protein biomarkers helping to shape cancer outcomes. The tumour microenvironment (TME) is no longer considered a passive backdrop to cancer. It is a dynamic ecosystem that plays a central role in tumour growth, immune suppression,… Read More

#News

#AI #Drug development #Life sciences

State-of-the-art life sciences hub opened in London

Victoria House has been officially opened in London’s Bloomsbury Square as the capital’s state-of-the-art life sciences hub. The building was opened on Tuesday at a launch event which brought together leaders from science, academia, venture capital and the UK parliament. It is hoped Victoria House can help the UK achieve… Read More

#News

Molecules
#Drug development #Drug discovery #Webinar

Webinar: Driving breakthroughs with structure-guided drug design

The first challenge in drug discovery is selecting a biological target and validating it as a ‘druggable’ binding site. The key to this is identifying several potent compounds that can be used in more advanced validating assays. To achieve this go/no-go point, good chemical starting points need to be found… Read More

#News

UK financial markets
#AstraZeneca #Drug development #Investment #UK

AstraZeneca halts £200m research investment in UK 

AstraZeneca has halted its planned £200 ($270) million investment in a research facility in Cambridge, UK, according to reports from Reuters.  The investment, which was anticipated to generate 1,000 new jobs, is currently on hold.  The pharmaceutical company's decision indicates that none of its newly announced funding, initially revealed in… Read More

#Business & Investment #News

Cancer research lab
#Cancer research #Drug development #Drug discovery #Oncology

UK immigration system is a barrier to cancer research, says CRUK 

A new report from Cancer Research UK (CRUK) indicates that the UK immigration system is having a detrimental effect on research in the UK.  CRUK’s institutes are led by and made up of a combination of UK and international researchers, but now it says that the UK… Read More

#News

#Ajna Biosciences #Botanical #Drug development #Plant-based #Therapeutics

New podcast: Redefining the future with plant-based therapeutics

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Joel Stanley, CEO… Read More

#News

Red blood cells
#Cardiovascular disease #Clinical trials #Drug development

Baxdrostat offers hope for stubborn high blood pressure 

A new treatment has been shown to significantly lower blood pressure in people whose levels stay dangerously high despite medication, according to the results of a Phase III clinical trial.  The international BaxHTN trial, led by Professor Bryan Williams, UCL Institute of Cardiovascular Science, and sponsored by… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

New vodcast: In Conversation With Nick Slack, START Center for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#News

Cancer research
#Cancer research #Drug development #Drug discovery #Interview #START Center for Cancer Research (START) #Vodcast

Vodcast: In Conversation With Nick Slack, START Centre for Cancer Research

In the In Conversation With series, a part of the free DDW podcast and vodcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with Nick Slack, Chairman and CEO of… Read More

#Videos

#AI / data analytics / healthtech / informatics #Drug development #Drug discovery #Generative AI

From knowledge to creation: keeping up with AI 

Generative AI is now rapidly disrupting entire industries and new technology breakthroughs are emerging at pace. As new iterations push the boundaries of deep research and insight generation, the implications for life sciences are both profound and uncertain. Reflecting on the rapid progression of GenAI, and its potential to propel… Read More

#Exclusive Content

Back pain
#Chronic low back pain #Chronic pain #Drug development #Non-opioid #Persica Pharmaceuticals

New podcast: A non-opioid approach to chronic low back pain

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Steve Ruston, CEO… Read More

#News